Skip to content

Growth Hormone Deficiency and Empty Sella Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study

Growth Hormone Deficiency, Empty Sella and Cardio-Metabolic Risk Factors in Obesity: a Cross-Sectional Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02092779
Enrollment
447
Registered
2014-03-20
Start date
2007-03-31
Completion date
2014-03-31
Last updated
2014-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Obesity is a disease not always attributable to nutritional imbalance, frequently associated with changes in key hypothalamic-pituitary (HP) axes. The regain of weight loss after hypochaloric diets has been ascribed to these HP disregulations. The aim of the study is to explore pituitary morphology and its association with pituitary function and metabolic phenotype in outpatient obese individuals evaluated in the period 2010-2013 at the Department of Experimental Medicine of the University of Rome La Sapienza, with features of HP disease in a cross-sectional .

Interventions

None listed

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adult obese

Exclusion criteria

* psychiatric disturbances, pregnancy, lactation, or drugs known to affect pituitary function

Design outcomes

Primary

MeasureTime frame
Cranio-caudal pituitary diameter in millimetersParticipants will be followed for the duration of day hospital stay, an expected average of 1 week

Secondary

MeasureTime frame
Growth hormone releasing hormone plus arginine test for GH secretion μg/LParticipants will be followed for the duration of day hospital stay, an expected average of 1 week

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026